slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 34,021-34,050
Pages 2,019
Rows per page 30
Component
34,021-34,050 of 60,568
13
Includes reconciliation for 'Elimination of Dual Credit' and 'Corporate & Unallocated' items.3M | Results Presentation Deck | 15 slides · 3M
Conference presentation Investor relations 1 hit
14
The slide presents a comprehensive financial table split into two columns of business groups.3M | Results Presentation Deck | 15 slides · 3M
Conference presentation Investor relations 1 hit
06
Highlights the disparity between standard charging speeds and the need for ultra-fast charging solutions.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations Beat · Problem IdentificationLoop · Cost Of Inaction1 hit
11
Includes detailed breakdown of utility, construction, and equipment costs, plus a comparison of permitting/installation timelines.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
12
The table highlights the cost-avoidance capability of the ChargeBox technology by comparing monthly and annual peak demand charges.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
13
The table breaks down CAPEX and operational costs including installation, maintenance, electricity, and peak demand charges.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
19
Includes detailed footnotes explaining specific line item adjustments.AgroFresh | Investor Conference Presentation Deck | 19 slides · AgroFresh
Conference presentation Investor relations 1 hit
05
Alkermes | Investor Conference Presentation Deck | 36 slidesAlkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations 1 hit
29
The slide uses a matrix-like layout to organize clinical trials (ARTISTRY series) by their strategic purpose (Registration, Dose, Collaboration).Alkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
Anghami | SPAC Presentation Deck | 29 slidesAnghami | SPAC Presentation Deck | 29 slides · Anghami
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
06
Includes pro forma merger context and non-GAAP financial disclosures.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
07
Includes footnotes regarding fee-related performance fees and adjusted operating income definitions.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
08
The table includes quarterly data from 1Q'19 to 3Q'21, plus full-year totals for 2019 and 2020, and YTD 2021 figures.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Benchmark Gap1 hit
14
Includes footnotes explaining specific adjustments like transaction-related charges and equity-based compensation.Apollo Global Management | Other Presentation Deck | 20 slides · Apollo Global Management
Conference presentation Investor relations Beat · Evidence & ProofLoop · So What Cascade1 hit
11
Clinical trial baseline characteristics table.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
Clinical trial safety data table.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide presents clinical trial baseline data for three cohorts.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
21
Includes a landmark analysis at 9 months for hazard ratios.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Clinical trial data presentation showing PFS, HR, and TTP metrics.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
23
Clinical trial safety data comparing combination therapy vs monotherapy vs standard of care.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The table displays both 'All grades' and 'Grade ≥3' adverse events for specific medical conditions.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
38
AstraZeneca | Investor Day Presentation Deck | 42 slidesAstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
AstraZeneca | Investor Day Presentation Deck | 42 slidesAstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations 1 hit
05
Includes a highlighted row for RL-007 and a section for equity interests.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
28
The table maps study types (HV PK, Scopolamine, Peripheral Diabetic Neuropathy) against Phase 1/2 status and key clinical endpoints (Safety/PK, Target Engaged, Biphasic).ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
34
The table uses directional arrows to indicate the direction of change in qEEG endpoints across different cohorts and brain regions (F, C, T, P, O).ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
37
The chart highlights a non-linear dose-response relationship where 40mg appears to be the peak efficacy point across the measured tasks.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
40
The table maps study types against phases and outcomes (Safety/PK, Target Engaged, Biphasic).ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
08
The slide uses a color-coded table structure to present performance metrics across different operational domains.Babylon | Investor Conference Presentation Deck | 15 slides · Babylon
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
The table includes adjustments for impairments, restructuring, share-based compensation, and other non-recurring items.Bausch Health Companies | Investor Conference Presentation Deck | 26 slides · Bausch Health
Conference presentation Investor relations 1 hit